2950 Alexeev, Vitali - Thomas Jefferson University - Thomas Jefferson University

Vitali Alexeev, PhD

Contact Dr. Alexeev

233 S. 10th Street
Room 319
Philadelphia, PA 19107

(215) 503-4835

Most Recent Peer-reviewed Publications

  1. Fibulin-4 E57K knock-in mice recapitulate cutaneous, vascular and skeletal defects of recessive cutis laxa 1B with both elastic fiber and collagen fibril abnormalities
  2. The triterpenoid RTA 408 is a robust mitigator of hematopoietic acute radiation syndrome in mice
  3. Targeting the mRNA-binding protein HuR impairs malignant characteristics of pancreatic ductal adenocarcinoma cells
  4. Radiation protection of the gastrointestinal tract and growth inhibition of prostate cancer xenografts by a single compound
  5. Human adipose-derived stem cell transplantation as a potential therapy for collagen VI-related congenital muscular dystrophy
  6. Chemokine-enhanced DNA vaccination in cancer immunotherapy
  7. Immunotargeting and eradication of orthotopic melanoma using a chemokine-enhanced DNA vaccine
  8. Analysis of chemotactic molecules in bone marrow-derived mesenchymal stem cells and the skin: Ccl27-Ccr10 axis as a basis for targeting to cutaneous tissues
  9. Interleukin 10 in the tumor microenvironment: A target for anticancer immunotherapy
  10. Gene expression signatures of mouse bone marrow-derived mesenchymal stem cells in the cutaneous environment and therapeutic implications for blistering skin disorder
  11. Targeted manipulation of mammalian genomes using designed zinc finger nucleases
  12. Human interleukin 10 receptor 1/IgG1-Fc fusion proteins: Immunoadhesins for human IL-10 with therapeutic potential
  13. Retroviral delivery of ECM genes.
  14. MicroRNA-dependent regulation of cKit in cutaneous melanoma
  15. Site-specific gene modification by oligodeoxynucleotides in mouse bone marrow-derived mesenchymal stem cells
  16. Oligonucleotide-mediated gene targeting in human hepatocytes: Implications of mismatch repair
  17. Protein therapeutics for junctional epidermolysis bullosa: Incorporation of recombinant β3 chain into laminin 332 in β3-/- keratinocytes in vitro
  18. Immunotherapeutic strategies for the treatment of malignant melanoma
  19. Characterization of the CCL21-mediated melanoma-specific immune responses and in situ melanoma eradication
  20. RNAi-mediated silencing of insulin receptor substrate 1 (IRS-1) enhances tamoxifen-induced cell death in MCF-7 breast cancer cells